GSA Capital Partners’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-109,685
| Closed | -$138K | – | 2048 |
|
|
2022
Q4 | $138K | Sell |
109,685
-7,729
| -7% | -$9.72K | 0.02% | 1264 |
|
|
2022
Q3 | $505K | Buy |
117,414
+93,954
| +400% | +$404K | 0.07% | 563 |
|
|
2022
Q2 | $122K | Buy |
23,460
+2,467
| +12% | +$12.8K | 0.02% | 1186 |
|
|
2022
Q1 | $252K | Sell |
20,993
-3,796
| -15% | -$45.6K | 0.03% | 1027 |
|
|
2021
Q4 | $485K | Buy |
24,789
+24,084
| +3,416% | +$471K | 0.06% | 617 |
|
|
2021
Q3 | $18K | Buy |
+705
| New | +$18K | ﹤0.01% | 1363 |
|
|
2021
Q1 | – | Sell |
-1,130
| Closed | -$19K | – | 1605 |
|
|
2020
Q4 | $19K | Buy |
+1,130
| New | +$19K | ﹤0.01% | 1149 |
|
|
2019
Q3 | – | Sell |
-3,239
| Closed | -$75K | – | 1794 |
|
|
2019
Q2 | $75K | Buy |
3,239
+1,209
| +60% | +$28K | 0.01% | 1362 |
|
|
2019
Q1 | $78K | Buy |
2,030
+705
| +53% | +$27.1K | 0.01% | 1348 |
|
|
2018
Q4 | $61K | Buy |
+1,325
| New | +$61K | 0.01% | 1256 |
|